title: Everolimus associated interstitial pneumonitis in a liver transplant patient.
abstract: Drug-induced interstitial lung disease is associated with significant morbidity and mortality. Everolimus is an inhibitor of mTOR, a mammalian target of rapamycin, used as an immunosuppressant agent in solid organ transplant. Everolimus has been associated with interstitial lung disease in solid organ transplant patients but has been rarely reported in the liver transplant patient population. We report a case of interstitial pneumonitis in a liver transplant patient associated with everolimus which completely resolved after discontinuation of the medication.
authors.affiliation: Division of Pulmonary and Critical Care, Houston Methodist Hospital, 6565 Fannin St, Houston, TX 77030, USA.
authors.forename: Atif S
authors.initials: AS
authors.lastname: Siddiqui
authors.affiliation: Division of Critical Care, Houston Methodist Hospital, 6565 Fannin St, Houston, TX 77030, USA.
authors.forename: Janice L
authors.initials: JL
authors.lastname: Zimmerman
keywords: Everolimus; Interstitial pneumonitis; Liver transplantation